Oct 14 (Reuters) – Parabilis Medicines Inc: * PARABILIS MEDICINES INITIATES DOSE-RANGING CLINICAL STUDY OF ZOLUCATETIDE IN FAMILIAL ADENOMATOUS POLYPOSIS * PARABILIS MEDICINES – TO DISCLOSE ADDITIONAL
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Oct 14 (Reuters) - Indian tyre maker CEAT on Wednesday reported a nearly 40% fall…
VIDEO SHOWS: VISSEL KOBE PLAY JEONBUK HYUNDAI MOTORS IN THE ASIAN CHAMPIONS LEAGUE ELITE TEMPLATE…
(Adds analyst quotes, background) * Implied odds of October Fed rate hike rise to about…
Pune (Maharashtra) [India], October 14: FITTR, a technology-enabled preventive-healthcare company, today announced its collaboration with…
By Tharuniyaa Lakshmi and Purvi Agarwal Oct 14 (Reuters) - Wall Street's main indexes were…
Oct 14 (Reuters) - AI industry leaders are split over how fast companies should develop…